BCL2L11 and acute lymphoblastic leukemia: A study performed in the T-ALL cell line, Jurkat, showed that EGR1 binds and transactivates the BIM locus.64 However, in our microarray study EGR1 was strongly downregulated by the combination treatment and BIM was upregulated.